Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Moderate Allocation
  • Asset Class: Mixed Allocation
  • Geographic Focus: Multi

NB PHARMAFUND FI

+ Add to Watchlist

PHARMFD:SM

20.80 EUR 0.04 0.20%

As of 00:59:30 ET on 05/21/2015.

Snapshot for NB PHARMAFUND FI (PHARMFD)

Year To Date: +20.32% 3-Month: +8.34% 3-Year: +24.83% 52-Week Range: 14.38 - 21.26
1-Month: -1.19% 1-Year: +41.99% 5-Year: +16.51% Beta vs MSGUPHA: 0.86

Mutual Fund Chart for PHARMFD

No chart data available.
  • PHARMFD:SM 20.80
  • 1M
  • 1Y
Interactive PHARMFD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for PHARMFD

NB PHARMAFUND FI is an open-end fund incorporated in Spain. The Fund's objective is capital accumulation. The Fund invests in international equity securities that are engaged in the pharmaceutical and biotechnology sectors.

Inception Date: 05-15-1997 Telephone: 34-90-212-3252
Managers: -
Web Site: www.esgestion.com

Fundamentals for PHARMFD

NAV (on 2015-05-21) 20.80
Assets (M) (on 2015-05-20) 8.28
Fund Leveraged N
Minimum Investment 10.00
Minimum Subsequent Investment -

Dividends for PHARMFD

No dividends reported

Fees & Expenses for PHARMFD

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 2.25
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for PHARMFD

Filing Date: 02/28/2015
Name Position Value % of Total
SGLT 0 04/10/15 935 934,406 12.476%
Amgen Inc 3,809 536,580 7.164%
Allergan Inc/United States 2,550 530,088 7.078%
Pfizer Inc 16,000 490,461 6.549%
Novartis AG 5,200 474,467 6.335%
Actavis plc 1,800 468,424 6.254%
Mylan NV 6,721 344,124 4.595%
Novo Nordisk A/S 7,750 332,035 4.433%
Bristol-Myers Squibb Co 5,940 323,209 4.315%
Bayer AG 2,420 319,561 4.267%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil